US EditionmRNA Research by IBM, Moderna Shows Quantum’s Present-Day Uses
7 Articles
7 Articles
How IBM and Moderna’s partnership could lead to an explosion in drug development
IBM: International Business Machines . . . or “Incredible Breakthroughs in Medicine”? IBM may need to tweak its moniker in light of recent news, because its latest work in quantum computing, in partnership with Moderna, could lead to potentially explosive breakthroughs in the medical field. The companies’ recently published research showed “promise” when using a combination of quantum and classical computers to “predict mRNA secondary structures…
How quantum computing and AI can accelerate and improve drug
RIYADH: Using traditional discovery processes, a staggering 90 percent of drug development trials are unsuccessful. But what if there is a future in which quantum technologies could revolutionize that process to achieve unprecedented efficiency? The race to develop quantum computers has been surging worldwide. In April, IBM announced a $150 billion investment plan to
mRNA Research by IBM, Moderna Shows Quantum’s Present-Day Uses
The timeline for scaling quantum might be murky, but the tech is being put to use in the here and now. IBM and Moderna released research on Thursday advancing the use of quantum computing in the development of mRNA medicines, a rapidly growing field that was used in the development of the Covid-19 vaccine. The research uses both classical computing and quantum computing methods to tackle increasingly complex problems. Quantum computing was use…
Artificial intelligence continues to find new ground to be useful, and this time it has done so in an area that seemed unique to human thought: quantum physics. In a recent study, a group of researchers demonstrated that collaboration between humans and machine learning algorithms can unravel problems that, separately, none could solve. A challenge with little data and a lot of complexity One of the biggest challenges in applying artificial inte…
Moderna and IBM Demonstrate Quantum-Classical Approach for mRNA Secondary Structure Prediction - Quantum Computing Report
Moderna and IBM have published a new case study demonstrating the application of quantum and classical computing in predicting mRNA secondary structures, a complex step in designing mRNA-based medicines. This collaboration is an extension of their ongoing partnership to explore how emerging quantum algorithms can address the limitations of classical computing in mRNA development. The [...] The post Moderna and IBM Demonstrate Quantum-Classical A…
Quantum computing edges closer to biotech reality in Moderna
In 2022, Moderna brought in approximately $19.26 billion in revenue, largely thanks to its groundbreaking Spikevax COVID-19 vaccine. In January 2025, the company is projecting revenue of $1.5 billion to $2.5 billion. To reverse this downturn, the company is pushing to broaden mRNA’s applications into cancer, rare diseases and other areas, but that requires cracking… The post Quantum computing edges closer to biotech reality in Moderna-IBM pact a…
Coverage Details
Bias Distribution
- 33% of the sources lean Left, 33% of the sources are Center, 33% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
